MEDINET Co., Ltd. (TYO:2370)
30.00
0.00 (0.00%)
At close: Feb 6, 2026
MEDINET Revenue
In the fiscal year ending September 30, 2018, MEDINET had annual revenue of 998.00M JPY, down -41.43%. MEDINET had revenue of 228.00M in the quarter ending September 30, 2018, a decrease of -41.54%.
Revenue
998.00M
Revenue Growth
-41.43%
P/S Ratio
7.96
Revenue / Employee
10.85M
Employees
92
Market Cap
7.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2018 | 998.00M | -706.00M | -41.43% |
| Sep 30, 2017 | 1.70B | -205.00M | -10.74% |
| Sep 30, 2016 | 1.91B | 235.00M | 14.04% |
| Sep 30, 2015 | 1.67B | -169.00M | -9.17% |
| Sep 30, 2014 | 1.84B | -267.00M | -12.65% |
| Sep 30, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Linical | 9.87B |
| Soiken Holdings | 4.87B |
| CellSource | 3.71B |
| StemCell Institute | 2.72B |
| OncoTherapy Science | 956.00M |
| Chiome Bioscience | 727.99M |
| PRISM BioLab Co.,LTD | 677.33M |
| ADR120S | 49.00M |